Shri Ram Economics Summit 2024: A Confluence of Ideas and Innovation indianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianexpress.com Daily Mail and Mail on Sunday newspapers.
Innovation, talent, government support, and funding are crucial for Indian pharma to achieve its target of $130 billion by 2030 and $500 billion by 2047. Learn more about the insights from top CEOs in the industry.
Glenmark partners with Pfizer to launch oral drug for atopic dermatitis in India financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has received marketing authorization for abrocitinib in adults with moderate-to-severe atopic dermatitis from the Central Drugs Standard Control Organization (CDSCO). It is also approved by the USFDA, European Medicines Agency (EMA), and other regulatory agencies.